Influenza Vaccines; Carbapenems; Infectious Disease Transmission, Professional-to-Patient; Drug Resistance, Multiple, Bacterial; Infectious Disease Medicine; Vancomycin-Resistant Enterococci; Transplant Recipients
My current research focuses on the epidemiology, prevention and outcomes of infections with multi-drug resistant bacterial pathogens. The organisms of focus include vancomycin-resistant enterococci (VRE) and multi-drug resistant gram-negative organisms, including those resistant to carbapenem antibiotics.
Specialized Terms; Healthcare-associated infections; Influenza vaccination; Infections in solid organ transplant recipients
- Banach D, Francois J, Blash S, Patel G, Jenkins S, LaBombardi V, Kreisworth B, Srinivasan A, Calfee D. Active Surveillance for Carbapenem-Resistant Enterobacteriaeciae using Stool Specimens Tested for Clostridium difficile. Infection Control and Hospital Epidemiology. (accepted, in press).
- Banach D, Zhang C, Factor S, Calfee D. Support for Mandatory Healthcare Worker Influenza Vaccination among Allied Health Professionals, Technical Staff, and Medical Students. American Journal of Infection Control. 2013:41(4):354-356.
- Barría MI, Garrido JL, Scher E, Ge Y, Engel SM, Stein CR, Kraus TA, Banach D, Moran TM. Intranasal, Live Attenuated Influenza Vaccine (LAIV) induces a Localized Mucosal Immune Response in Adults. Journal of Infectious Diseases 2013:207(1):115-124.
- Banach D, Bielang R, Calfee D. Factors Associated with Unprotected Exposure to 2009 H1N1 Influenza A among Healthcare Workers during the First Wave of the Pandemic. Infection Control and Hospital Epidemiology 2011;32(3):293-295.
- Banach D, Harris T. “Indeterminate QuantiFERON TB-Gold® results in a Public Health Clinic Setting.” International Journal of Tuberculosis and Lung Disease 2011:15(12):1623-1629.